Aripiprazole Injection: Pharmacokinetics and Safety in Chinese Adults
A groundbreaking clinical study has unveiled critical insights into the pharmacokinetics, safety, and tolerability of Aripiprazole once-monthly (AOM), a long-acting ...
Tag: long-acting injectable antipsychotics
Incentives Boost Long-Acting Antipsychotic Use
In recent years, the challenge of ensuring consistent adherence to antipsychotic medication among patients with serious mental illness has remained ...
Paliperidone Palmitate Boosts Schizophrenia Care Outcomes
The realm of schizophrenia treatment has witnessed a compelling advancement with recent research highlighting the potential of paliperidone palmitate once-monthly ...
10-Year Study: Aripiprazole LAI’s Patient Impact
In the realm of psychiatric treatment, the pursuit of long-term efficacy and patient adherence remains a formidable challenge. A recent ...
Long-Acting Injectable vs Oral Antipsychotics: First-Episode Outcomes
In the complex landscape of psychosis treatment, the decision between prescribing oral antipsychotic medications or long-acting injectable (LAI) therapies has ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!